Most of the synthesized compounds showed moderate activity. In order to suggest the mechanism of action for their cytotoxic activity, molecular docking for all synthesized compounds was done on the active site of phosphoinositide kinase (PI3K) and good results were obtained.
Many quinoline derivatives possess a wide variety in pharmacological activity. [1] [2] [3] The quinoline pattern is found in a large number of natural products and drug-like compounds known as antitumor agents, such as Camptothecin, 4) Luotonin, 5) Ascididemin, 6) TAS-103, 7) Cryptolepin, 8) Indolo [2,3-b] quinolines. 9) In addition, sulfonamides constitute an important class of drugs with several types of pharmacological activities including antibacterial, 10) anti-carbonic anhydrase, 11) diuretic, 12) hypoglycemic, 13) antitumor 2) and antithyroid activity. 14) Some structurally novel sulfonamide derivatives have recently been reported to show substantial antitumor activity in vitro and/or in vivo. Compounds such as E7010 A, ER-34410 B, E7070 Indisulam C, QBS D and the quinoline derivative E are examples for antitumor sulfonamides in advanced clinical trials. 15) It has been known that aryl/heteroaryl sulfonamides may act as antitumor agents through a variety of mechanisms such as cell cycle perturbation in the G1 phase, disruption of microtubule assembly, angiogenesis inhibition, and functional suppression of the transcriptional activator NF-Y. Moreover, following an extensive evaluation, numerous sulfonamides were found to act as carbonic anhydrase (CA) inhibitors. [16] [17] [18] Recently, combination of quinoline nuclues with sulfonamide moieties has received a great attention in seeking for novel anticancer agents. 19) Several quinoline sulfonamide derivatives showed potent anticancer activity as phosphoinisitol kinase (PI3K) inhibitors. 19) In view of the above mentioned findings and as a part of our research effort to explore novel anticancer heterocyclic compounds 20, 21) we have synthesized a new series of chloroquinoline derivatives having biologically active sulfonamide moiety as analogues for compounds A-E. The cytotoxic activity of the newly synthesized compounds were evaluated through in vitro antitumor screening on several cell lines. Moreover, as a trial to suggest the mechanism of action of these compounds virtual docking on the active site of PI3K was performed.
Results and Discussion
Chemistry Several compounds were designed with the aim of exploring their anticancer properties (Charts 1-3). The present work reports the possible utility of 4,7-dichloroquinoline 1 in the synthesis of 7-chloroquinolinesulfonamide derivatives 2-17 and 19-25. Quninolinesulfonamide derivatives 2-14 were obtained in good yield by the reaction of compound 1 with several sulfonamides in dry N,N-dimethylformamide (DMF), whereas, conducting this reaction in the presence of anhydrous potassium carbonate 22) afforded the corresponding sulfonamide derivative 16. The structures of 2-14 and 16 were supported by elemental analysis and spectral data. The IR spectra of compounds 2-14 revealed the presence of bands for NH, CH aromatic, C= N, SO 2 and C-Cl. IR spectrum for compound 16 showed bands at 3454, 3389 and 3244 cm (C-Cl). 1 H-NMR spectra of compounds 2-14 in (DMSOd 6 ) indicated the presence of a doublet at 6.5-8.6 ppm which could be assigned to 2CH of pyridine and a singlet at 10.2-10.7 ppm for NHph. 6 ) showed signals at 9.1, 9.2 ppm assigned to 2NH of ureido groups.
Isothiocyanate derivatives are useful and widely used as building blocks in the synthesis of nitogen, sulfur and oxygen containing heterocyclic compounds and organometallic compounds of academic, pharmaceutical and industrial interest. Thus, the isothiocyanate derivative 18 was synthesized by treatment of compound 1 with ammonium thiocyanate in dry acetone for 1 h. This method lead to a higher overall yield and shorter working time in comparison with the reported method by using silver thiocyanate. 23) IR spectrum of 18 showed band at 2072 cm −1 (N= C=S). The reactivity of isothiocyanate derivative 18 towards amino compounds such as sulfonamides was discussed. Thus, interaction of compound 18 with sulfonamides in DMF in the presence of triethylamine yielded the corresponding carbamimidothioic acid derivatives 19-25, respectively. The structures of compounds 19-25 were supported by analytical and spectral data. The IR spectra of compounds 19-25 showed the absence of (N= C=S) band and presence of bands for (NH), (C= N), (SO 2 ) and (C-Cl) groups. 1 H-NMR spectra in (DMSO-d 6 ) for compounds 19-25 showed signals at 2.2-2.5 ppm for SH groups, and 8.4-8.9 ppm due to SO 2 NH group. Molecular Docking Oncology drug discovery has benefited significantly from progress in understanding how to target kinases with small molecules relative to other disease indications. The constitutive activity of this class of kinase target makes them essential for survival and/or proliferation of the cancer cell. This so-called oncogene addiction. 24, 25) A recent example is that PTen-deficient cancers depend on PI3Kβ to sustain activation of the PI3K pathway, whereas PI3Kα kinase activity appears to be required to sustain the proliferation of established tumours. 26, 27) Like the majority of protein kinase inhibitors, all existing PI3K inhibitors bind competitively in the ATP-binding pocket of the catalytic domain. This strategy has enabled the development of both pan-PI3K-and isoformspecific inhibitors. Loosely discriminate inhibitors that target multiple PI3K isoforms may more thoroughly shut down PI3K signaling for the treatment of acute life-threatening diseases. 28) The PI3K (phosphoinositide 3-kinase) pathway is often overactive in human cancers, and various genetic alterations have been found to cause this. In all cases, PI3K inhibition is considered to be one of the most promising targeted therapies for cancer treatment. In our investigation three different cell lines were chosen for in vitro assay. It was reported that these cell lines were affected by PI3K inhibitors with high cytotoxic activity. 29, 30) Based on the previous findings and as a trial to suggest the mechanism of action of the cytotoxic activity for the synthesized compounds docking of all newly synthesized compounds was done on the active site of PI3K.
The protein data bank file (PDB: 3S2A) was selected for this purpose. The file contains PI3K enzyme co-crystallized with a quinoline ligand. All docking procedures were achieved by Molecular Operating Environment (MOE) software 10.2008 provided by chemical computing group, Canada. Docking on the active site of PI3K enzyme was performed for all synthesized compounds. The best amino acid interactions were formed with compound 19 with Lys 890 with a hydrogen bond of 2.92 Å, Lys 833 with a hydrogen bond of 2.52, 3.06 Å, Asp 864 with a hydrogen bond of 3.24, 3.62 Å and Tyr 867 through a water molecule with a hydrogen bond of 2.93 Å, Fig. 3 .
In Vitro Antitumor Activity The newly synthesized compounds were evaluated for their in vitro cytotoxic activity against human breast cancer cell line (MDA-MB231), skin cancer cell line (HT 1080) and neuroblastoma cell line (SH-SY5Y). Doxorubicin which is one of the most effective anticancer agents was used as the reference drug in this study. The relationship between surviving fraction and drug concentration was plotted to obtain the survival curve of cancer cell lines. The response parameter calculated was the IC 50 value, which corresponds to the concentration required for 50% inhibition of cell viability. Table 2 shows the in vitro cytotoxic activity of the synthesized compounds where all compounds exhibited moderate activity compared to the reference drug in case of human breast cancer cell line (MDA-MB231), while compounds 19-25 where inactive in case of skin cancer cell line (HT 1080). Also compounds 20-23 and 25 were inactive in case of neuroblastoma cell line (SH-SY5Y).
All the synthesized compounds showed moderate cytotoxic activity compared to Doxorubicin on human breast cancer cell line (MDA-MB231). The For compounds 2-14 better activity also was observed for 6-membered substituted sulfonamide derivatives 9-14 than unsubstituted 2, acetyl 3, guanidine 4 and 5-membered substituted derivatives 5-8. On the other hand, the sulfonamide phenyl urea derivative 15 showed better activity than compound 16 with IC 50 value 109.40 µm and 140.99 µm, respectively.
Most of the synthesized compounds showed moderate cytotoxic activity compared to Doxorubicin on neuroblastoma cell Relationship between Molecular Docking and in Vitro Screening The inhibition of PI3K could be a suggested mechanism for the cytotoxic activity of the synthesized compound. This can be demonstrated by the docking results that were performed on the active site of PI3K. The co-crystalized quinoline ligand intearcts with the amino acids of the active site by six interaction that were mentioned before. On the other hand, the newly synthesized compounds interact with these amino acids by 1, 2, 3 or 4 interactions. We could postulate a relationship between the number on amino acid interactions and the in vitro cytotoxic activity on the used cell lines. Most of the synthesized compounds interact with the amino acids of the active site by 3 interactions. 
Experimental
Chemistry Melting points (°C, uncorrected) were determined in open capillaries on a Gallenkemp melting point apparatus (Sanyo Gallenkemp, Southborough, U.K.) and were uncorrected. Pre-coated silica gel plates (silica gel 0.25 mm, 60 G F254; Merck, Germany) were used for thin layer chromatography, dichloromethane-methanol (9.5 : 0.5) mixture was used as a developing solvent system and the spots were visualized by UV light and/or iodine. Infra-red spectra were recorded in KBr discs using IR-470 Shimadzu spectrometer (Shimadzu, Tokyo, Japan). NMR spectra (in DMSO-d 6 ) were recorded on Bruker AC-300 Ultra Shield NMR spectrometer (Bruker, Flawil, Switzerland, δ ppm) at 500 MHz using TMS as internal standard and peak multiplicities are designed as follows: s, singlet; d, doublet; t, triplet; m, multiplet. Elemental analyses were performed on Carlo Erba 1108 Elemental Analyzer (Heraeus, Hanau, Germany).
General Procedure for the Synthesis of Compounds 2-14 A mixture of 1 (1.98 g, 0.01 mol) and the corresponding sulfonamide (0.012 mol) in dry DMF (20 mL) was refluxed for 6 h. The solid obtained after concentration was filtered and crystallized from dioxane to give 2-14. 4 -(7-Chloroqui noli n-4 -yl-ami no) -N -(4,6 -di met hylpyrimidin-2-yl) benzenesulfonamide (12) (DMSD-d 6 ) δ: 53.6, 54.3, 84.1, 112.4, 118.6(2), 121.0,  123.8, 127.2, 129.0(2), 129.3, 133.0, 137.2, 147.8, 148.6, 150.5,  153.3, 162.2, 163.3, 173.6 . Anal. Calcd for C 21 ( (2), 124.0, 126.1 (2), 126.3, 126.9, 127.4, 128.1, 134.0 with MMFF94X force field and the partial charges were automatically calculated. The X-ray crystallographic structure of PI3K complexe with its ligand (PDB ID: 3S2A) was obtained from the protein data bank. The enzyme was prepared for docking studies where: (i) Ligand molecule was removed from the enzyme active site.
4-(7-
(ii) Hydrogen atoms were added to the structure with their standard geometry. (iii) MOE Alpha Site Finder was used for the active sites search in the enzyme structure and dummy atoms were created from the obtained alpha spheres. (iv) The obtained model was then used in predicting the ligand enzymes interactions at the active site Biological Screening. In Vitro Antitumor Activity Human breast cancer cell line (MDA-MB231), skin cancer cell line (HT 1080) and neuroblastoma cell line (SH-SY5Y) were used in this study. The cytotoxic activity was measured in vitro for the newly synthesized compounds using the SulfoRhodamine-B stain (SRB) assay using the method of Skehan et al. 31) The in vitro anticancer screening was done by the pharmacology unit at Pharmacognosy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Cells were plated in 96-multiwell plate (10 4 cells/well) for 24 h before treatment with the compound(s) to allow attachment of cell to the wall of the plate. Test compounds were dissolved in dimethyl sulfoxide. Different concentrations of the compound under test (5, 12.5, 25, 50 µm) were added to the cell monolayer. Triplicate wells were prepared for each individual concentration. Monolayer cells were incubated with the compound(s) for 48 h at 37°C and in atmosphere of 5% CO 2 . After 48 h, cells were fixed, washed and stained for 30 min with 0.4% (wt/vol) SRB dissolved in 1% acetic acid. Excess unbound dye was removed by four washes with 1% acetic acid and attached stain was recovered with Trise-ethylenediaminetetraacetic acid (EDTA) buffer. Color intensity was measured in an enzyme-linked immunosorbent assay (ELISA) reader. The relation between surviving fraction and drug concentration is plotted to get the survival curve for cancer cell line after the specified time. The molar concentration required for 50% inhibition of cell viability (IC 50 ) was calculated and compared to the reference drug Doxorubicin (CAS, 25316-40-9) and the results are given in Table 2 .
